Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-κB activity

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Sha, Min ^a   Ye, Jun ^a   Zhang, Li Xin ^a   Luan, Zheng Yun ^a   Chen, Ya Bao ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Celastrol; Gastric cancer; MiR 146a; NF B

Indexed keywords

CELASTROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MICRORNA 146A;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 84878050153     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-50     Document Type: Article

References (22)

1. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008, 9(3):279-287. 10.1016/S1470-2045(08)70072-X, 18308253.
2. Sutter AP, Fechner H. Gene therapy for gastric cancer: is it promising?. World J Gastroenterol 2006, 12(3):380-387.
3. Salminen A, Lehtonen M, Paimela T, Kaarniranta K. Celastrol: molecular targets of thunder God vine. Biochem Biophys Res Commun 2010, 394(3):439-442. 10.1016/j.bbrc.2010.03.050, 20226165.
4. Morita T. Celastrol: a new therapeutic potential of traditional Chinese medicine. Am J Hypertens 2010, 23(8):821. 10.1038/ajh.2010.87, 20644533.
5. Kannaiyan R, Shanmugam MK, Sethi G. Molecular targets of celastrol derived from thunder of God vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett 2011, 303(1):9-20. 10.1016/j.canlet.2010.10.025, 21168266.
6. Kannaiyan R, Manu KA, Chen L, Li F, Rajendran P, Subramaniam A, Lam P, Kumar AP, Sethi G. Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. Apoptosis 2011, 16(10):1028-1041. 10.1007/s10495-011-0629-6, 21786165.
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
8. Winter J, Jung S, Keller S, Gregory RI, Diederich S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009, 11(3):228-234. 10.1038/ncb0309-228, 19255566.
9. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353(17):1793-1801. 10.1056/NEJMoa050995, 16251535.
10. Hou Z, Xie L, Yu L, Qian X, Liu B. MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis. Med Oncol 2012, 29(2):886-892. 10.1007/s12032-011-9862-7, 21347720.
11. Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH, Friis-Hansen L. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer 2012, 11:71. 10.1186/1476-4598-11-71, 3515505, 22992343.
12. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, Katano M. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001, 7(12):4136-4142.
13. Baud V, Karin M. Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 2009, 8(1):33-40. 10.1038/nrd2781, 2729321, 19116625.
14. Dutta J, Fan Y, Gupta N, Fan G, Gélinas C. Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 2006, 25(51):6800-6816. 10.1038/sj.onc.1209938, 17072329.
15. Lee JH, Koo TH, Yoon H, Jung HS, Jin HZ, Lee K, Hong YS, Lee JJ. Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem Pharmacol 2006, 72(10):1311-1321. 10.1016/j.bcp.2006.08.014, 16984800.
16. He D, Xu Q, Yan M, Zhang P, Zhou X, Zhang Z, Duan W, Zhong L, Ye D, Chen W. The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. BMC Cancer 2009, 9:343. 10.1186/1471-2407-9-343, 2760578, 19778460.
17. Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 2004, 5(5):392-401. 10.1038/nrm1368, 15122352.
18. Wang XN, Wu Q, Yang X, Zhang LS, Wu YP, Lu C. Effects of Celastrol on growth inhibition of U937 leukemia cells through the regulation of the Notch1/NF-kappaB signaling pathway in vitro. Chin J Cancer 2010, 29(4):385-390. 10.5732/cjc.009.10526, 20346213.
19. Zhou LL, Lin ZX, Fung KP, Cheng CH, Che CT, Zhao M, Wu SH, Zuo Z. Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-κB activity. Eur J Pharmacol 2011, 670(2-3):399-408.
20. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 2009, 1(4):a000034. 10.1101/cshperspect.a000034, 2773619, 20066092.
21. Ma T, Zhu ZG, Ji YB, Zhang Y, Yu YY, Liu BY, Yin HR, Lin YZ. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2¢-deoxyuridine. World J Gastroenterol 2004, 10:172-176.
22. Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods 2000, 243:167-190. 10.1016/S0022-1759(00)00233-7, 10986414.